Radiopharmaceutical Theranostics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

Jul 2021| TMR2421A| Transparency

Report Highlights

Radiopharmaceutical Theranostics Market – Scope of Report

TMR’s report on the global radiopharmaceutical theranostics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031. The report provides revenue of the global  radiopharmaceutical theranostics market for the period of 2017–2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global radiopharmaceutical theranostics market from 2021 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the radiopharmaceutical theranostics market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global radiopharmaceutical theranostics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global radiopharmaceutical theranostics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global radiopharmaceutical theranostics market.

The report delves into the competitive landscape of the global radiopharmaceutical theranostics market. Key players operating in the global radiopharmaceutical theranostics market have been identified and each one of these is profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global radiopharmaceutical theranostics market profiled in this report.

Key Questions Answered in Radiopharmaceutical Theranostics Market Report

  • What is the sales/revenue generated by the radiopharmaceutical theranostics market across all regions during the forecast period?
  • What are the opportunities in the global radiopharmaceutical theranostics market?
  • What are the major drivers, restraints, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Radiopharmaceutical Theranostics Market – Research Objectives and Research Approach

The comprehensive report on the global radiopharmaceutical theranostics market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global radiopharmaceutical theranostics market in terms of radioisotope, application, source, end user, approach, and region. Key segments under each criterion are studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global radiopharmaceutical theranostics market.

  • Table 1 : FDA Approved Radiopharmaceuticals Products
  • Table 2 : Radiopharmaceuticals used in diagnostic applications along with their important physical properties
  • Table 3 : Radiopharmaceuticals used in therapeutic applications along with their important physical properties
  • Table 4 : List of Current and Future Radiopharmaceutical Theranostics Pairs
  • Table 5 : Global Radiopharmaceutical Theranostics Market Revenue (US$ Mn) Forecast, by Radioisotope, 2017–2031
  • Table 6 : Global Radiopharmaceutical Theranostics Market Revenue (US$ Mn) Forecast, by Application, 2017–2031
  • Table 7 : Global Radiopharmaceutical Theranostics Market Revenue (US$ Mn) Forecast, by Source, 2017–2031
  • Table 8 : Global Radiopharmaceutical Theranostics Market Revenue (US$ Mn) Forecast, by Approach, 2017–2031
  • Table 9 : Global Radiopharmaceutical Theranostics Market Revenue (US$ Mn) Forecast, by End-user, 2017–2031
  • Table 10 : Global Radiopharmaceutical Theranostics Market Value (US$ Mn) Forecast, by Region, 2017–2031
  • Table 11 : North America Radiopharmaceutical Theranostics Market Value (US$ Mn) Forecast, by Country, 2017–2031
  • Table 12 : North America Radiopharmaceutical Theranostics Market Value (US$ Mn) Forecast, by Radioisotope, 2017–2031
  • Table 13 : North America Radiopharmaceutical Theranostics Market Revenue (US$ Mn) Forecast, by Application, 2017–2031
  • Table 14 : North America Radiopharmaceutical Theranostics Market Revenue (US$ Mn) Forecast, by Source, 2017–2031
  • Table 15 : North America Radiopharmaceutical Theranostics Market Revenue (US$ Mn) Forecast, by Approach, 2017–2031
  • Table 16 : North America Radiopharmaceutical Theranostics Market Revenue (US$ Mn) Forecast, by End-user, 2017–2031
  • Table 17 : Europe Radiopharmaceutical Theranostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
  • Table 18 : Europe Radiopharmaceutical Theranostics Market Value (US$ Mn) Forecast, by Radioisotope, 2017–2031
  • Table 19 : Europe Radiopharmaceutical Theranostics Market Revenue (US$ Mn) Forecast, by Application, 2017–2031
  • Table 20 : Europe Radiopharmaceutical Theranostics Market Revenue (US$ Mn) Forecast, by Source, 2017–2031
  • Table 21 : Europe Radiopharmaceutical Theranostics Market Revenue (US$ Mn) Forecast, by Approach, 2017–2031
  • Table 22 : Europe Radiopharmaceutical Theranostics Market Revenue (US$ Mn) Forecast, by End-user, 2017–2031
  • Table 23 : Asia Pacific Radiopharmaceutical Theranostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
  • Table 24 : Asia Pacific Radiopharmaceutical Theranostics Market Value (US$ Mn) Forecast, by Radioisotope, 2017–2031
  • Table 25 : Asia Pacific Radiopharmaceutical Theranostics Market Revenue (US$ Mn) Forecast, by Application, 2017–2031
  • Table 26 : Asia Pacific Radiopharmaceutical Theranostics Market Revenue (US$ Mn) Forecast, by Source, 2017–2031
  • Table 27 : Asia Pacific Radiopharmaceutical Theranostics Market Revenue (US$ Mn) Forecast, by Approach, 2017–2031
  • Table 28 : Asia Pacific Radiopharmaceutical Theranostics Market Revenue (US$ Mn) Forecast, by End-user, 2017–2031
  • Table 29 : Latin America Radiopharmaceutical Theranostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
  • Table 30 : Latin America Radiopharmaceutical Theranostics Market Value (US$ Mn) Forecast, by Radioisotope, 2017–2031
  • Table 31 : Latin America Radiopharmaceutical Theranostics Market Revenue (US$ Mn) Forecast, by Application, 2017–2031
  • Table 32 : Latin America Radiopharmaceutical Theranostics Market Revenue (US$ Mn) Forecast, by Source, 2017–2031
  • Table 33 : Latin America Radiopharmaceutical Theranostics Market Revenue (US$ Mn) Forecast, by Approach, 2017–2031
  • Table 34 : Latin America Radiopharmaceutical Theranostics Market Revenue (US$ Mn) Forecast, by End-user, 2017–2031
  • Table 35 : Middle East & Africa Radiopharmaceutical Theranostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
  • Table 36 : Middle East & Africa Radiopharmaceutical Theranostics Market Value (US$ Mn) Forecast, by Radioisotope, 2017–2031
  • Table 37 : Middle East & Africa Radiopharmaceutical Theranostics Market Revenue (US$ Mn) Forecast, by Application, 2017–2031
  • Table 38 : Middle East & Africa Radiopharmaceutical Theranostics Market Revenue (US$ Mn) Forecast, by Source, 2017–2031
  • Table 39 : Middle East & Africa Radiopharmaceutical Theranostics Market Revenue (US$ Mn) Forecast, by Approach, 2017–2031
  • Table 40 : Middle East & Africa Radiopharmaceutical Theranostics Market Revenue (US$ Mn) Forecast, by End-user, 2017–2031
  • Figure 1 : Global Radiopharmaceutical Theranostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
  • Figure 2 : Global Radiopharmaceutical Theranostics Market Value Share, by Region, 2020
  • Figure 3 : Global Radiopharmaceutical Theranostics Market Value Share Analysis, by Radioisotope, 2020 and 2031
  • Figure 4 : Global Radiopharmaceutical Theranostics Market Attractiveness Analysis, by Radioisotope, 2021–2031
  • Figure 5 : Global Radiopharmaceutical Theranostics Market Revenue (US$ Mn), by Technetium-99, 2017–2031
  • Figure 6 : Global Radiopharmaceutical Theranostics Market Revenue (US$ Mn), by Gallium-68 , 2017–2031
  • Figure 7 : Global Radiopharmaceutical Theranostics Market Revenue (US$ Mn), by Iodine-131, 2017–2031
  • Figure 8 : Global Radiopharmaceutical Theranostics Market Revenue (US$ Mn), by Iodine-123, 2017–2031
  • Figure 9 : Global Radiopharmaceutical Theranostics Market Revenue (US$ Mn), by 18F , 2017–2031
  • Figure 10 : Global Radiopharmaceutical Theranostics Market Revenue (US$ Mn), by Y-90, 2017–2031
  • Figure 11 : Global Radiopharmaceutical Theranostics Market Revenue (US$ Mn), by Lutetium (Lu) 177, 2017–2031
  • Figure 12 : Global Radiopharmaceutical Theranostics Market Revenue (US$ Mn), by Copper (Cu) 67, 2017–2031
  • Figure 13 : Global Radiopharmaceutical Theranostics Market Revenue (US$ Mn), by Copper (Cu) 64, 2017–2031
  • Figure 14 : Global Radiopharmaceutical Theranostics Market Revenue (US$ Mn), by Others, 2017–2031
  • Figure 15 : Global Radiopharmaceutical Theranostics Market Value Share Analysis, by Application, 2020 and 2031
  • Figure 16 : Global Radiopharmaceutical Theranostics Market Attractiveness Analysis, by Application, 2021–2031
  • Figure 17 : Global Radiopharmaceutical Theranostics Market Revenue (US$ Mn), by Oncology, 2017–2031
  • Figure 18 : Global Radiopharmaceutical Theranostics Market Revenue (US$ Mn), by Cardiology, 2017–2031
  • Figure 19 : Global Radiopharmaceutical Theranostics Market Value Share Analysis, by Source, 2020 and 2031
  • Figure 20 : Global Radiopharmaceutical Theranostics Market Attractiveness Analysis, by Source, 2021–2031
  • Figure 21 : Global Radiopharmaceutical Theranostics Market Revenue (US$ Mn), by Nuclear Reactors, 2017–2031
  • Figure 22 : Global Radiopharmaceutical Theranostics Market Revenue (US$ Mn), by Cyclotrons, 2017–2031
  • Figure 23 : Global Radiopharmaceutical Theranostics Market Value Share Analysis, by Approach, 2020 and 2031
  • Figure 24 : Global Radiopharmaceutical Theranostics Market Attractiveness Analysis, by Approach, 2021–2031
  • Figure 25 : Global Radiopharmaceutical Theranostics Market Revenue (US$ Mn), by Targeted Therapeutic (Rx), 2017–2031
  • Figure 26 : Global Radiopharmaceutical Theranostics Market Revenue (US$ Mn), by Companion Diagnostic (DX), 2017–2031
  • Figure 27 : Global Radiopharmaceutical Theranostics Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 28 : Global Radiopharmaceutical Theranostics Market Attractiveness Analysis, by End-user, 2021–2031
  • Figure 29 : Global Radiopharmaceutical Theranostics Market Revenue (US$ Mn), by Hospitals, 2017–2031
  • Figure 30 : Global Radiopharmaceutical Theranostics Market Revenue (US$ Mn), by Academic & Research Institutes, 2017–2031
  • Figure 31 : Global Radiopharmaceutical Theranostics Market Value Share Analysis, by Region, 2020 and 2031
  • Figure 32 : Global Radiopharmaceutical Theranostics Market Attractiveness Analysis, by Region, 2021–2031
  • Figure 33 : North America Radiopharmaceutical Theranostics Market Value (US$ Mn) Forecast, 2017–2031
  • Figure 34 : North America Radiopharmaceutical Theranostics Market Value Share Analysis, by Country, 2020 and 2031
  • Figure 35 : North America Radiopharmaceutical Theranostics Market Attractiveness Analysis, by Country, 2021–2031
  • Figure 36 : North America Radiopharmaceutical Theranostics Market Value Share Analysis, by Radioisotope, 2020 and 2031
  • Figure 37 : North America Radiopharmaceutical Theranostics Market Attractiveness Analysis, by Radioisotope, 2021–2031
  • Figure 38 : North America Radiopharmaceutical Theranostics Market Value Share Analysis, by Application, 2020 and 2031
  • Figure 39 : North America Radiopharmaceutical Theranostics Market Attractiveness Analysis, by Application, 2021–2031
  • Figure 40 : North America Radiopharmaceutical Theranostics Market Value Share Analysis, by Source, 2020 and 2031
  • Figure 41 : North America Radiopharmaceutical Theranostics Market Attractiveness Analysis, by Source, 2021–2031
  • Figure 42 : North America Radiopharmaceutical Theranostics Market Value Share Analysis, by Approach, 2020 and 2031
  • Figure 43 : North America Radiopharmaceutical Theranostics Market Attractiveness Analysis, by Approach, 2021–2031
  • Figure 44 : North America Radiopharmaceutical Theranostics Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 45 : North America Radiopharmaceutical Theranostics Market Attractiveness Analysis, by End-user, 2021–2031
  • Figure 46 : Europe Radiopharmaceutical Theranostics Market Value (US$ Mn) Forecast, 2017–2031
  • Figure 47 : Europe Radiopharmaceutical Theranostics Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
  • Figure 48 : Europe Radiopharmaceutical Theranostics Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
  • Figure 49 : Europe Radiopharmaceutical Theranostics Market Value Share Analysis, by Radioisotope, 2020 and 2031
  • Figure 50 : Europe Radiopharmaceutical Theranostics Market Attractiveness Analysis, by Radioisotope, 2021–2031
  • Figure 51 : Europe Radiopharmaceutical Theranostics Market Value Share Analysis, by Application, 2020 and 2031
  • Figure 52 : Europe Radiopharmaceutical Theranostics Market Attractiveness Analysis, by Application, 2021–2031
  • Figure 53 : Europe Radiopharmaceutical Theranostics Market Value Share Analysis, by Source, 2020 and 2031
  • Figure 54 : Europe Radiopharmaceutical Theranostics Market Attractiveness Analysis, by Source, 2021–2031
  • Figure 55 : Europe Radiopharmaceutical Theranostics Market Value Share Analysis, by Approach, 2020 and 2031
  • Figure 56 : Europe Radiopharmaceutical Theranostics Market Attractiveness Analysis, by Approach, 2021–2031
  • Figure 57 : Europe Radiopharmaceutical Theranostics Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 58 : Europe Radiopharmaceutical Theranostics Market Attractiveness Analysis, by End-user, 2021–2031
  • Figure 59 : Asia Pacific Radiopharmaceutical Theranostics Market Value (US$ Mn) Forecast, 2017–2031
  • Figure 60 : Asia Pacific Radiopharmaceutical Theranostics Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
  • Figure 61 : Asia Pacific Radiopharmaceutical Theranostics Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
  • Figure 62 : Asia Pacific Radiopharmaceutical Theranostics Market Value Share Analysis, by Radioisotope, 2020 and 2031
  • Figure 63 : Asia Pacific Radiopharmaceutical Theranostics Market Attractiveness Analysis, by Radioisotope, 2021–2031
  • Figure 64 : Asia Pacific Radiopharmaceutical Theranostics Market Value Share Analysis, by Application, 2020 and 2031
  • Figure 65 : Asia Pacific Radiopharmaceutical Theranostics Market Attractiveness Analysis, by Application, 2021–2031
  • Figure 66 : Asia Pacific Radiopharmaceutical Theranostics Market Value Share Analysis, by Source, 2020 and 2031
  • Figure 67 : Asia Pacific Radiopharmaceutical Theranostics Market Attractiveness Analysis, by Source, 2021–2031
  • Figure 68 : Asia Pacific Radiopharmaceutical Theranostics Market Value Share Analysis, by Approach, 2020 and 2031
  • Figure 69 : Asia Pacific Radiopharmaceutical Theranostics Market Attractiveness Analysis, by Approach, 2021–2031
  • Figure 70 : Asia Pacific Radiopharmaceutical Theranostics Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 71 : Asia Pacific Radiopharmaceutical Theranostics Market Attractiveness Analysis, by End-user, 2021–2031
  • Figure 72 : Latin America Radiopharmaceutical Theranostics Market Value (US$ Mn) Forecast, 2017–2031
  • Figure 73 : Latin America Radiopharmaceutical Theranostics Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
  • Figure 74 : Latin America Radiopharmaceutical Theranostics Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
  • Figure 75 : Latin America Radiopharmaceutical Theranostics Market Value Share Analysis, by Application, 2020 and 2031
  • Figure 76 : Latin America Radiopharmaceutical Theranostics Market Attractiveness Analysis, by Application, 2021–2031
  • Figure 77 : Latin America Radiopharmaceutical Theranostics Market Value Share Analysis, by Source, 2020 and 2031
  • Figure 78 : Latin America Radiopharmaceutical Theranostics Market Attractiveness Analysis, by Source, 2021–2031
  • Figure 79 : Latin America Radiopharmaceutical Theranostics Market Value Share Analysis, by Approach, 2020 and 2031
  • Figure 80 : Latin America Radiopharmaceutical Theranostics Market Attractiveness Analysis, by Approach, 2021–2031
  • Figure 81 : Latin America Radiopharmaceutical Theranostics Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 82 : Latin America Radiopharmaceutical Theranostics Market Attractiveness Analysis, by End-user, 2021–2031
  • Figure 83 : Middle East & Africa Radiopharmaceutical Theranostics Market Value (US$ Mn) Forecast, 2017–2031
  • Figure 84 : Middle East & Africa Radiopharmaceutical Theranostics Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
  • Figure 85 : Middle East & Africa Radiopharmaceutical Theranostics Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
  • Figure 86 : Middle East & Africa Radiopharmaceutical Theranostics Market Value Share Analysis, by Radioisotope, 2020 and 2031
  • Figure 87 : Middle East & Africa Radiopharmaceutical Theranostics Market Attractiveness Analysis, by Radioisotope, 2021–2031
  • Figure 88 : Middle East & Africa Radiopharmaceutical Theranostics Market Value Share Analysis, by Application, 2020 and 2031
  • Figure 89 : Middle East & Africa Radiopharmaceutical Theranostics Market Attractiveness Analysis, by Application, 2021–2031
  • Figure 90 : Middle East & Africa Radiopharmaceutical Theranostics Market Value Share Analysis, by Source, 2020 and 2031
  • Figure 91 : Middle East & Africa Radiopharmaceutical Theranostics Market Attractiveness Analysis, by Source, 2021–2031
  • Figure 92 : Middle East & Africa Radiopharmaceutical Theranostics Market Value Share Analysis, by Approach, 2020 and 2031
  • Figure 93 : Middle East & Africa Radiopharmaceutical Theranostics Market Attractiveness Analysis, by Approach, 2021–2031
  • Figure 94 : Middle East & Africa Radiopharmaceutical Theranostics Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 95 : Middle East & Africa Radiopharmaceutical Theranostics Market Attractiveness Analysis, by End-user, 2021–2031

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report